Neil Pearce - Publications#

Checkoway H, Pearce N, Kriebel D. Research methods in occupational epidemiology. 2nd ed. New York: Oxford University Press, 2004 [ISBN 0-19-509242-2].

Pearce N, Beasley R, Burgess C, Crane J. Asthma epidemiology: principles and methods. New York: Oxford University Press, 1998 [ISBN 0-19-508016-5].

Recent journal papers (selected)

Strachan DP, Rutter CE, Asher MI, Bissell K, Chiang C-Y, El Sony A, Ellwood E, Ellwood P, García-Marcos L, Marks GB, Morales E, Mortimer K, Pearce N, VPérez-Fernández P, Robertson S, Silverwood RJ, and the Global Asthma Network Phase I Study Group. Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I. Paediatric Allergy and Immunology, in press [DOI: 10.1111/pai.13656]].

Asher MI, Rutter CE, Bissell K, Chiang C-Y, El Sony A, Ellwood E, Ellwood P, García-Marcos L, Marks GB, Morales E, Mortimer K, Pérez-Fernández V, Robertson S, Silverwood RJ, Strachan DP, Pearce N, and the Global Asthma Network Phase I Study Group. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I: cross-sectional study. Lancet 2021; 398: 1569-1580. [doi.org/10.1016/S0140-6736(21)01450-1]].

Meghji J, Mortimer K, Agusti A, Allwood BW, Asher I, Bateman ED, Bissell K, Bolton CE, Bush A, Celli B, Chiang C-Y, Cruz AA, Dinh-Xuan AT, El Sony A, Fujiwara PI, Gaga M, Garcia-Marcos L, Halpin DMG, Hurst JR, Jayasooriya S, Kumar A, Lopez Varela MV, Masekela R, Mbatchou Ngahane BH, Montes de Oca M, Pearce N, Reddel HK, Salvi S, Singh SJ, Varghese C, Vogelmeier CF, Walker P, Zar HJ, Marks GB. Improving lung health in low- and middle-income countries: from challenges to solutions. Lancet 2021; 397: 928-940.

Mpairwe H, Nkurunungi G, Tumwesige P, Akurut H, Namutebi M, Nambuya I, Nnaluwooza M, Apule B, Onen C, Katongole T, Niwagaba E, Mukasa M, Webb EL, Elliott AL, Pearce N. Risk factors for rhinitis, allergic conjunctivitis and eczema among schoolchildren in Uganda. Clinical and Experimental Allergy 2021; 51: 108-119.

Asher MI, Garcia-Marcos L, Pearce N, Strachan D. Trends in world-wide asthma prevalence. European Respiratory Journal 2020; 56: 2002094 [doi.org/10.1183/13993003.02094-2020]].

Vandenbroucke JP, Brickley EB, Vandenbroucke-Grauls CMJE, Pearce N. A Test-Negative Design with additional population controls can be used to rapidly study causes of the SARS-CoV-2 epidemic. Epidemiology 2020; 31: 836-843.

Vandenbroucke J, Pearce N. Test-negative designs: differences and commonalities with other case-control studies with ‘other patient’ controls. Epidemiology 2019; 30: 838-844.

Rutter C, Silverwood RJ, Williams HC, Ellwood, Asher I, Garcia-Marcos L, Strachan DP, Pearce N, Langan SM, and the ISAAC Phase Three Study Group. Are environmental factors for atopic eczema in ISAAC Phase Three due to reverse causation? Journal of Investigative Dermatology 2019; 139: 1023-1036.

Silverwood R, Rutter C, Mitchell E, Asher I, Garcia-Marcos L, Strachan D, Pearce N, and the ISAAC Phase Three Study Group. Are environmental risk factors for current wheeze in the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three due to reverse causation? Clinical and Experimental Allergy 2019; 49: 430-441.

Vandenbroucke J, Pearce N. From ideas to studies: how to get ideas and sharpen them into research questions. Clinical Epidemiology 2018; 10: 253-264.

Checkoway H, Pearce N, Kriebel D. Research methods in occupational epidemiology. 2nd ed. New York: Oxford University Press, 2004 [ISBN 0-19-509242-2]].

Pearce N, Beasley R, Burgess C, Crane J. Asthma epidemiology: principles and methods. New York: Oxford University Press, 1998 [ISBN 0-19-508016-5].

Asher MI, Rutter CE, Bissell K, Chiang C-Y, El Sony A, Ellwood E, Ellwood P, García-Marcos L, Marks GB, Morales E, Mortimer K, Pérez-Fernández V, Robertson S, Silverwood RJ, Strachan DP, Pearce N, and the Global Asthma Network Phase I Study Group. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I: cross-sectional study. Lancet 2021; 398: 1569-1580. Citations = 2

Cerqueira-Silva T, Katikireddi SV, de Araujo Oliveira V, Flores-Ortiz R, Bertoldo Júnior V, Paixão ES, Robertson C, Penna GO, Werneck GL, Barreto ML, Pearce N, Sheikh A, Barral-Netto M, Boaventura VS. Waning of CoronaVac and vaccine effectiveness of BNT162b2 boosters in Brazil. Nature Medicine, in press.

Crane J, Pearce NE, Flatt A, Burgess C, Jackson R, Kwong T, Ball M, Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-1983: a case-control study. Lancet 1989; 333: 917-922. Citations = 446

Pearce N, Beasley R, Crane J, Burgess C, Jackson R. End of the New Zealand asthma mortality epidemic. Lancet 1995; 345: 41-44. Citations = 145

Beasley R, Keil U, Von Mutius E, Pearce N, Ait-Khaled N, Anabwani G, Anderson HR, Asher MI, Björkstén B, Burr ML, Clayton TO, Crane J, Ellwood P, Lai CKW, Mallol J, Martinez FD, Mitchell EA, Montefort S, Robertson CF, Shah JR, Sibbald B, Stewart AW, Strachan DP, Weiland SK, Williams HC (ISAAC Steering Committee). Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema: ISAAC. Lancet 1998; 351: 1225-1232. Citations = 3254

Pearce N, Pekkanen J, Beasley R. How much asthma is really attributable to atopy? Thorax 1999; 54: 268-272. Citations = 516

Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002; 57: 643-648. IF = 6.8, citations = 469

Pearce N, Aït-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, Robertson C, and the ISAAC Phase Three Study group. Worldwide trends in the prevalence of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62: 757-765. Citations = 850